Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001567619-22-011714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | 2022-05-23 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $48.76 | -2,656 | 968.8K | -0.3% | -$129.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-05-23 | S | D | 2,656 | $48.76 | 968,817 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |